US2020077943A1PendingUtilityA1

System for analyzing and treating abnormality of human and animal tissues

Assignee: TRUERELIEF LLCPriority: Jun 2, 2003Filed: Nov 5, 2019Published: Mar 12, 2020
Est. expiryJun 2, 2023(expired)· nominal 20-yr term from priority
A61B 5/742A61B 5/0035A61B 5/053A61N 2/008A61N 2/02A61N 5/10G01R 33/60A61N 2005/1087A61N 2/002A61B 5/4836A61N 1/36021A61N 2005/1091A61B 5/055
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A patient treatment unit for analyzing and treating abnormality of human or animal tissues, includes a display; a pulse generator circuit that outputs a sequence of electrical pulses at a pulse frequency, the electrical pulses having a pulse width, the pulse generator controlling the pulse frequency and the pulse width of the electrical pulses; a pair of probes for contacting a body of a patient and electrically coupled to the pulse generator; and a voltage and current sensing circuit that senses a voltage or a current via the probes when contacting the body of the patient.

Claims

exact text as granted — not AI-modified
I claim: 
     
         1 . A patient treatment unit for analyzing and treating abnormality of human or animal tissues, comprising:
 a display;   a pulse generator circuit that outputs a sequence of electrical pulses at a pulse frequency, the electrical pulses having a pulse width, the pulse generator controlling the pulse frequency and the pulse width of the electrical pulses;   a pair of probes for contacting a body of a patient and electrically coupled to the pulse generator; and   a voltage and current sensing circuit that senses a voltage or a current via the probes when contacting the body of the patient.   
     
     
         2 . The patient treatment unit of  claim 1 , further comprising a circuit for detecting an overvoltage or an overcurrent in the electrical pulses. 
     
     
         3 . The patient treatment unit of  claim 1 , wherein the electrical pulses are substantially rectangular pulses when the probes have a substantially open circuit between them. 
     
     
         4 . The patient treatment unit of  claim 1 , wherein the pulse frequency is in a range of 1-490 Hz±6% from 500 ohms to 1 mega-ohm of resistance across the probes. 
     
     
         5 . The patient treatment unit of  claim 1 , wherein the pulse width is not less than 0.34 milliseconds and is not greater than 0.74 milliseconds. 
     
     
         6 . The patient treatment unit of  claim 1 , wherein a peak voltage of the electrical pulses across the probes when a 500 ohm resistance is present across the probes does not exceed about 4 volts. 
     
     
         7 . The patient treatment unit of  claim 1 , wherein a peak voltage of the electrical pulses across the probes when a 5 kilo-ohm resistance is present across the probes does not exceed about 30 volts. 
     
     
         8 . The patient treatment unit of  claim 1 , wherein a peak voltage of the electrical pulses across the probes when a 10 kilo-ohm resistance is present across the probes does not exceed about 40 volts. 
     
     
         9 . The patient treatment unit of  claim 1 , wherein one of the probes includes a potentiometer for adjusting a characteristic of the electrical pulses. 
     
     
         10 . The patient treatment unit of  claim 1 , wherein the characteristic is the pulse frequency. 
     
     
         11 . The patient treatment unit of  claim 1 , wherein the maximum current output of the pulse generator circuit is not greater than 8.9 milliamps. 
     
     
         12 . The patient treatment unit of  claim 1 , wherein the maximum charge of electrical pulse does not exceed 7 micro-coulombs. 
     
     
         13 . The patient treatment unit of  claim 1 , wherein the pulse generator circuit includes current and voltage limiting means. 
     
     
         14 . The patient treatment unit of  claim 1 , further comprising a microcontroller for controlling the display. 
     
     
         15 . A patient treatment unit for analyzing and treating abnormality of human or animal tissues, comprising:
 a display controlled by a microcontroller;   a pulse generator circuit including current and voltage limiting means, the pulse generator circuit outputting a sequence of electrical pulses at a pulse frequency, the electrical pulses having a pulse width, the pulse generator controlling the pulse frequency and the pulse width of the electrical pulses, wherein the pulse width is not less than 0.34 milliseconds and is not greater than 0.74 milliseconds, wherein the maximum current output of the pulse generator circuit is not greater than 8.9 milliamps, wherein the maximum charge of electrical pulse does not exceed 7 micro-coulombs;   a pair of probes for contacting a body of a patient and electrically coupled to the pulse generator, wherein the electrical pulses are substantially rectangular pulses when the probes have a substantially open circuit between them, wherein one of the probes includes a potentiometer for adjusting a characteristic of the electrical pulses;   a voltage and current sensing circuit that senses a voltage or a current via the probes when contacting the body of the patient, wherein a peak voltage of the electrical pulses across the probes when a 500 ohm resistance is present across the probes does not exceed about 4 volts; and   a circuit for detecting an overvoltage or an overcurrent in the electrical pulses.   
     
     
         16 . The patient treatment unit of  claim 15 , wherein the pulse frequency is in a range of 1-490 Hz±6% from 500 ohms to 1 mega-ohm of resistance across the probes. 
     
     
         17 . The patient treatment unit of  claim 15 , wherein a peak voltage of the electrical pulses across the probes when a 5 kilo-ohm resistance is present across the probes does not exceed about 30 volts, and wherein a peak voltage of the electrical pulses across the probes when a 10 kilo-ohm resistance is present across the probes does not exceed about 40 volts. 
     
     
         18 . The patient treatment unit of  claim 15 , wherein the characteristic is the pulse frequency. 
     
     
         19 . The patient treatment unit of  claim 16 , wherein a peak voltage of the electrical pulses across the probes when a 5 kilo-ohm resistance is present across the probes does not exceed about 30 volts, and wherein a peak voltage of the electrical pulses across the probes when a 10 kilo-ohm resistance is present across the probes does not exceed about 40 volts, and wherein the characteristic is the pulse frequency. 
     
     
         20 . A patient treatment unit for analyzing and treating abnormality of human or animal tissues, comprising:
 a display;   a microcontroller for controlling the display;   a pulse generator circuit that outputs a sequence of electrical pulses at a pulse frequency, the electrical pulses having a pulse width, the pulse generator controlling the pulse frequency and the pulse width of the electrical pulses, wherein the pulse generator circuit includes current and voltage limiting means;   a pair of probes for contacting a body of a patient and electrically coupled to the pulse generator;   a circuit for detecting an overvoltage or an overcurrent in the electrical pulses; and   a voltage and current sensing circuit that senses a voltage or a current via the probes when contacting the body of the patient, wherein one of the probes includes a potentiometer for adjusting the pulse frequency of the electrical pulses, wherein the maximum current output of the pulse generator circuit is not greater than 8.9 milliamps.

Join the waitlist — get patent alerts

Track US2020077943A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.